Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 208

1.

Fungicides, herbicides and bees: A systematic review of existing research and methods.

Cullen MG, Thompson LJ, Carolan JC, Stout JC, Stanley DA.

PLoS One. 2019 Dec 10;14(12):e0225743. doi: 10.1371/journal.pone.0225743. eCollection 2019.

2.

A global synthesis reveals biodiversity-mediated benefits for crop production.

Dainese M, Martin EA, Aizen MA, Albrecht M, Bartomeus I, Bommarco R, Carvalheiro LG, Chaplin-Kramer R, Gagic V, Garibaldi LA, Ghazoul J, Grab H, Jonsson M, Karp DS, Kennedy CM, Kleijn D, Kremen C, Landis DA, Letourneau DK, Marini L, Poveda K, Rader R, Smith HG, Tscharntke T, Andersson GKS, Badenhausser I, Baensch S, Bezerra ADM, Bianchi FJJA, Boreux V, Bretagnolle V, Caballero-Lopez B, Cavigliasso P, Ćetković A, Chacoff NP, Classen A, Cusser S, da Silva E Silva FD, de Groot GA, Dudenhöffer JH, Ekroos J, Fijen T, Franck P, Freitas BM, Garratt MPD, Gratton C, Hipólito J, Holzschuh A, Hunt L, Iverson AL, Jha S, Keasar T, Kim TN, Kishinevsky M, Klatt BK, Klein AM, Krewenka KM, Krishnan S, Larsen AE, Lavigne C, Liere H, Maas B, Mallinger RE, Martinez Pachon E, Martínez-Salinas A, Meehan TD, Mitchell MGE, Molina GAR, Nesper M, Nilsson L, O'Rourke ME, Peters MK, Plećaš M, Potts SG, Ramos DL, Rosenheim JA, Rundlöf M, Rusch A, Sáez A, Scheper J, Schleuning M, Schmack JM, Sciligo AR, Seymour C, Stanley DA, Stewart R, Stout JC, Sutter L, Takada MB, Taki H, Tamburini G, Tschumi M, Viana BF, Westphal C, Willcox BK, Wratten SD, Yoshioka A, Zaragoza-Trello C, Zhang W, Zou Y, Steffan-Dewenter I.

Sci Adv. 2019 Oct 16;5(10):eaax0121. doi: 10.1126/sciadv.aax0121. eCollection 2019 Oct.

3.

How different aspects of motor dysfunction influence day-to-day function in huntington's disease.

Carlozzi NE, Schilling SG, Boileau NR, Chou KL, Perlmutter JS, Frank S, McCormack MK, Stout JC, Paulsen JS, Lai JS, Dayalu P.

Mov Disord. 2019 Oct 14. doi: 10.1002/mds.27866. [Epub ahead of print]

PMID:
31609508
4.

Movement Disorder Society Task Force Viewpoint: Huntington's Disease Diagnostic Categories.

Ross CA, Reilmann R, Cardoso F, McCusker EA, Testa CM, Stout JC, Leavitt BR, Pei Z, Landwehrmeyer B, Martinez A, Levey J, Srajer T, Bang J, Tabrizi SJ.

Mov Disord Clin Pract. 2019 Aug 23;6(7):541-546. doi: 10.1002/mdc3.12808. eCollection 2019 Sep. No abstract available.

PMID:
31538087
5.

Discrete changes in the frequency and functions of autobiographical reminiscence in Huntington's disease.

Carmichael AM, Irish M, Glikmann-Johnston Y, Stout JC.

Memory. 2019 Nov;27(10):1345-1351. doi: 10.1080/09658211.2019.1654519. Epub 2019 Aug 19.

PMID:
31426716
6.

Validation of Neuro-QoL and PROMIS Mental Health Patient Reported Outcome Measures in Persons with Huntington Disease.

Carlozzi NE, Goodnight S, Kratz AL, Stout JC, McCormack MK, Paulsen JS, Boileau NR, Cella D, Ready RE.

J Huntingtons Dis. 2019;8(4):467-482. doi: 10.3233/JHD-190364.

PMID:
31424415
7.

Speech in prodromal and symptomatic Huntington's disease as a model of measuring onset and progression in dominantly inherited neurodegenerative diseases.

Chan JCS, Stout JC, Vogel AP.

Neurosci Biobehav Rev. 2019 Dec;107:450-460. doi: 10.1016/j.neubiorev.2019.08.009. Epub 2019 Aug 13. Review.

PMID:
31419452
8.

Association of CAG Repeats With Long-term Progression in Huntington Disease.

Langbehn DR, Stout JC, Gregory S, Mills JA, Durr A, Leavitt BR, Roos RAC, Long JD, Owen G, Johnson HJ, Borowsky B, Craufurd D, Reilmann R, Landwehrmeyer GB, Scahill RI, Tabrizi SJ; TRACK-HD and Track-On HD Groups.

JAMA Neurol. 2019 Aug 12. doi: 10.1001/jamaneurol.2019.2368. [Epub ahead of print]

PMID:
31403680
9.

Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD study.

Wilkes FA, Abaryan Z, Ching CRK, Gutman BA, Madsen SK, Walterfang M, Velakoulis D, Stout JC, Chua P, Egan GF, Thompson PM, Looi JCL, Georgiou-Karistianis N.

Psychiatry Res Neuroimaging. 2019 Sep 30;291:1-8. doi: 10.1016/j.pscychresns.2019.07.003. Epub 2019 Jul 12.

PMID:
31330407
10.

'Real-life' hippocampal-dependent spatial memory impairments in Huntington's disease.

Glikmann-Johnston Y, Carmichael AM, Mercieca EC, Stout JC.

Cortex. 2019 Oct;119:46-60. doi: 10.1016/j.cortex.2019.04.006. Epub 2019 Apr 15.

PMID:
31071556
11.

Intensity Matters: High-intensity Interval Exercise Enhances Motor Cortex Plasticity More Than Moderate Exercise.

Andrews SC, Curtin D, Hawi Z, Wongtrakun J, Stout JC, Coxon JP.

Cereb Cortex. 2019 May 1. pii: bhz075. doi: 10.1093/cercor/bhz075. [Epub ahead of print]

PMID:
31041988
12.

Meta-analysis reveals that pollinator functional diversity and abundance enhance crop pollination and yield.

Woodcock BA, Garratt MPD, Powney GD, Shaw RF, Osborne JL, Soroka J, Lindström SAM, Stanley D, Ouvrard P, Edwards ME, Jauker F, McCracken ME, Zou Y, Potts SG, Rundlöf M, Noriega JA, Greenop A, Smith HG, Bommarco R, van der Werf W, Stout JC, Steffan-Dewenter I, Morandin L, Bullock JM, Pywell RF.

Nat Commun. 2019 Apr 1;10(1):1481. doi: 10.1038/s41467-019-09393-6.

13.

Pervasive autobiographical memory impairments in Huntington's disease.

Carmichael AM, Irish M, Glikmann-Johnston Y, Singh P, Stout JC.

Neuropsychologia. 2019 Apr;127:123-130. doi: 10.1016/j.neuropsychologia.2019.02.017. Epub 2019 Feb 25.

PMID:
30817911
14.

Cognitive Fitness to Drive in Huntington's Disease: Assessing the Clinical Utility of DriveSafe DriveAware.

Farrell HJ, Andrews SC, Ryan NP, Davis MC, Gordon S, Stout JC, Fisher F.

J Huntingtons Dis. 2019;8(1):87-95. doi: 10.3233/JHD-180323.

PMID:
30776017
15.

Apathy Associated With Impaired Recognition of Happy Facial Expressions in Huntington's Disease.

Osborne-Crowley K, Andrews SC, Labuschagne I, Nair A, Scahill R, Craufurd D, Tabrizi SJ, Stout JC; TRACK-HD Investigators.

J Int Neuropsychol Soc. 2019 May;25(5):453-461. doi: 10.1017/S1355617718001224. Epub 2019 Feb 15.

16.

Spatial memory in Huntington's disease: A comparative review of human and animal data.

Glikmann-Johnston Y, Fink KD, Deng P, Torrest A, Stout JC.

Neurosci Biobehav Rev. 2019 Mar;98:194-207. doi: 10.1016/j.neubiorev.2019.01.015. Epub 2019 Jan 15. Review.

PMID:
30658070
17.

Physicochemical properties and phenolic content of honey from different floral origins and from rural versus urban landscapes.

Kavanagh S, Gunnoo J, Marques Passos T, Stout JC, White B.

Food Chem. 2019 Jan 30;272:66-75. doi: 10.1016/j.foodchem.2018.08.035. Epub 2018 Aug 9.

PMID:
30309595
18.

Juvenile Huntington's disease: left behind?

Stout JC.

Lancet Neurol. 2018 Nov;17(11):932-933. doi: 10.1016/S1474-4422(18)30334-X. Epub 2018 Sep 19. No abstract available.

PMID:
30243863
19.

Deep Brain Stimulation for Parkinson's disease changes perception in the Rubber Hand Illusion.

Ding C, Palmer CJ, Hohwy J, Youssef GJ, Paton B, Tsuchiya N, Stout JC, Thyagarajan D.

Sci Rep. 2018 Sep 14;8(1):13842. doi: 10.1038/s41598-018-31867-8.

20.

Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington's disease.

Andrews SC, Craufurd D, Durr A, Leavitt BR, Roos RA, Tabrizi SJ, Stout JC.

Neuropsychology. 2018 Nov;32(8):958-965. doi: 10.1037/neu0000479. Epub 2018 Sep 13.

PMID:
30211612
21.

Diminished facial EMG responses to disgusting scenes and happy and fearful faces in Huntington's disease.

Kordsachia CC, Labuschagne I, Andrews SC, Stout JC.

Cortex. 2018 Sep;106:185-199. doi: 10.1016/j.cortex.2018.05.019. Epub 2018 Jun 7.

PMID:
30005370
22.

Working Memory-Related Effective Connectivity in Huntington's Disease Patients.

Lahr J, Minkova L, Tabrizi SJ, Stout JC, Klöppel S, Scheller E; TrackOn-HD Investigators.

Front Neurol. 2018 Jun 4;9:370. doi: 10.3389/fneur.2018.00370. eCollection 2018.

23.

Understanding patient-reported outcome measures in Huntington disease: at what point is cognitive impairment related to poor measurement reliability?

Carlozzi NE, Schilling S, Kratz AL, Paulsen JS, Frank S, Stout JC.

Qual Life Res. 2018 Oct;27(10):2541-2555. doi: 10.1007/s11136-018-1912-6. Epub 2018 Jun 16.

24.

Reduced amygdala volumes are related to motor and cognitive signs in Huntington's disease: The IMAGE-HD study.

Ahveninen LM, Stout JC, Georgiou-Karistianis N, Lorenzetti V, Glikmann-Johnston Y.

Neuroimage Clin. 2018 Mar 22;18:881-887. doi: 10.1016/j.nicl.2018.03.027. eCollection 2018.

25.

Testing a longitudinal compensation model in premanifest Huntington's disease.

Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Johnson EB, Durr A, Roos RAC, Leavitt BR, Mills JA, Stout JC, Scahill RI, Tabrizi SJ, Rees G; Track-On investigators.

Brain. 2018 Jul 1;141(7):2156-2166. doi: 10.1093/brain/awy122.

26.

Agreement between clinician-rated versus patient-reported outcomes in Huntington disease.

Carlozzi NE, Boileau NR, Perlmutter JS, Chou KL, Stout JC, Paulsen JS, McCormack MK, Cella D, Nance MA, Lai JS, Dayalu P.

J Neurol. 2018 Jun;265(6):1443-1453. doi: 10.1007/s00415-018-8852-5. Epub 2018 Apr 23.

27.

Visual scanning of the eye region of human faces predicts emotion recognition performance in Huntington's disease.

Kordsachia CC, Labuschagne I, Stout JC.

Neuropsychology. 2018 Mar;32(3):356-365. doi: 10.1037/neu0000424.

PMID:
29620406
28.

Relationships Among Apathy, Health-Related Quality of Life, and Function in Huntington's Disease.

Fritz NE, Boileau NR, Stout JC, Ready R, Perlmutter JS, Paulsen JS, Quaid K, Barton S, McCormack MK, Perlman SL, Carlozzi NE; Huntington Disease Quality of Life Site Investigators and Coordinators, University of Michigan, University of Iowa, Indiana University, Johns Hopkins University, University of California, Rutgers University, Piscataway, Washington University, Struthers Parkinson’s Center, Cleveland Clinic Foundation, University of California, Northwestern University.

J Neuropsychiatry Clin Neurosci. 2018 Summer;30(3):194-201. doi: 10.1176/appi.neuropsych.17080173. Epub 2018 Mar 21.

29.

Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease.

Minkova L, Gregory S, Scahill RI, Abdulkadir A, Kaller CP, Peter J, Long JD, Stout JC, Reilmann R, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S; TRACK-HD Investigators.

Neuroimage Clin. 2017 Oct 25;17:312-324. doi: 10.1016/j.nicl.2017.10.023. eCollection 2018.

30.

Emotion Recognition Correlates With Social-Neuropsychiatric Dysfunction in Huntington's Disease.

Kempnich CL, Andrews SC, Fisher F, Wong D, Georgiou-Karistianis N, Stout JC.

J Int Neuropsychol Soc. 2018 May;24(5):417-423. doi: 10.1017/S1355617717001308. Epub 2017 Dec 28.

PMID:
29282160
31.

Rating scales for cognition in Huntington's disease: Critique and recommendations.

Mestre TA, Bachoud-Lévi AC, Marinus J, Stout JC, Paulsen JS, Como P, Duff K, Sampaio C, Goetz CG, Cubo E, Stebbins GT, Martinez-Martin P; Members of the MDS Committee on Rating Scales Development.

Mov Disord. 2018 Feb;33(2):187-195. doi: 10.1002/mds.27227. Epub 2017 Dec 26. Review.

PMID:
29278291
32.

Evaluating cognition in individuals with Huntington disease: Neuro-QoL cognitive functioning measures.

Lai JS, Goodnight S, Downing NR, Ready RE, Paulsen JS, Kratz AL, Stout JC, McCormack MK, Cella D, Ross C, Russell J, Carlozzi NE.

Qual Life Res. 2018 Mar;27(3):811-822. doi: 10.1007/s11136-017-1755-6. Epub 2017 Dec 8.

33.

Understanding the need for assistance with survey completion in people with Huntington disease.

Hahn EA, Downing NR, Stout JC, Paulsen JS, Ready B, Goodnight S, Lai JS, Miner JA, Carlozzi NE.

Qual Life Res. 2018 Mar;27(3):801-810. doi: 10.1007/s11136-017-1747-6. Epub 2017 Dec 6.

34.

Emotion recognition in Parkinson's disease: Static and dynamic factors.

Wasser CI, Evans F, Kempnich C, Glikmann-Johnston Y, Andrews SC, Thyagarajan D, Stout JC.

Neuropsychology. 2018 Feb;32(2):230-234. doi: 10.1037/neu0000400. Epub 2017 Oct 16.

PMID:
29035069
35.

Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis.

Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ; Track-HD and Track-On Investigators.

JAMA Neurol. 2017 Nov 1;74(11):1352-1360. doi: 10.1001/jamaneurol.2017.2107.

36.

Pilot Validation of Ambulatory Activity Monitors for Sleep Measurement in Huntington's Disease Gene Carriers.

Maskevich S, Jumabhoy R, Dao PDM, Stout JC, Drummond SPA.

J Huntingtons Dis. 2017;6(3):249-253. doi: 10.3233/JHD-170251.

PMID:
28968241
37.

Families Affected by Huntington's Disease Report Difficulties in Communication, Emotional Involvement, and Problem Solving.

Jona CMH, Labuschagne I, Mercieca EC, Fisher F, Gluyas C, Stout JC, Andrews SC.

J Huntingtons Dis. 2017;6(3):169-177. doi: 10.3233/JHD-170250.

38.

Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease.

Boileau NR, Stout JC, Paulsen JS, Cella D, McCormack MK, Nance MA, Frank S, Lai JS, Carlozzi NE.

J Huntingtons Dis. 2017;6(3):201-215. doi: 10.3233/JHD-170238.

39.

Oxytocin selectively modulates brain processing of disgust in Huntington's disease gene carriers.

Labuschagne I, Poudel G, Kordsachia C, Wu Q, Thomson H, Georgiou-Karistianis N, Stout JC.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Feb 2;81:11-16. doi: 10.1016/j.pnpbp.2017.09.023. Epub 2017 Sep 23.

PMID:
28947180
40.

Cognitive assessment in Huntington disease clinical drug trials.

Stout JC, Andrews SC, Glikmann-Johnston Y.

Handb Clin Neurol. 2017;144:227-244. doi: 10.1016/B978-0-12-801893-4.00019-5. Review.

PMID:
28947120
41.

Design optimization for clinical trials in early-stage manifest Huntington's disease.

Frost C, Mulick A, Scahill RI, Owen G, Aylward E, Leavitt BR, Durr A, Roos RAC, Borowsky B, Stout JC, Reilmann R, Langbehn DR, Tabrizi SJ, Sampaio C; TRACK-HD Investigators.

Mov Disord. 2017 Nov;32(11):1610-1619. doi: 10.1002/mds.27122. Epub 2017 Sep 14.

42.

Reduced Willingness to Expend Effort for Reward in Obesity: Link to Adherence to a 3-Month Weight Loss Intervention.

Mata F, Treadway M, Kwok A, Truby H, Yücel M, Stout JC, Verdejo-Garcia A.

Obesity (Silver Spring). 2017 Oct;25(10):1676-1681. doi: 10.1002/oby.21948. Epub 2017 Aug 7.

43.

Patient-reported outcome measures in Huntington disease: Quality of life in neurological disorders (Neuro-QoL) social functioning measures.

Carlozzi NE, Hahn EA, Goodnight SM, Kratz AL, Paulsen JS, Stout JC, Frank S, Miner JA, Cella D, Gershon RC, Schilling SG, Ready RE.

Psychol Assess. 2018 Apr;30(4):450-458. doi: 10.1037/pas0000479. Epub 2017 May 29.

44.

Longitudinal changes in the fronto-striatal network are associated with executive dysfunction and behavioral dysregulation in Huntington's disease: 30 months IMAGE-HD data.

Domínguez D JF, Poudel G, Stout JC, Gray M, Chua P, Borowsky B, Egan GF, Georgiou-Karistianis N.

Cortex. 2017 Jul;92:139-149. doi: 10.1016/j.cortex.2017.04.001. Epub 2017 Apr 15.

PMID:
28482181
45.

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington's disease.

McColgan P, Seunarine KK, Gregory S, Razi A, Papoutsi M, Long JD, Mills JA, Johnson E, Durr A, Roos RA, Leavitt BR, Stout JC, Scahill RI, Clark CA, Rees G, Tabrizi SJ; Track-On HD Investigators.

JCI Insight. 2017 Apr 20;2(8). pii: 92641. doi: 10.1172/jci.insight.92641. eCollection 2017 Apr 20.

46.

Abnormal Visual Scanning of Emotionally Evocative Natural Scenes in Huntington's Disease.

Kordsachia CC, Labuschagne I, Stout JC.

Front Psychol. 2017 Mar 29;8:405. doi: 10.3389/fpsyg.2017.00405. eCollection 2017.

47.

Feasibility and Efficacy of Brief Computerized Training to Improve Emotion Recognition in Premanifest and Early-Symptomatic Huntington's Disease.

Kempnich CL, Wong D, Georgiou-Karistianis N, Stout JC.

J Int Neuropsychol Soc. 2017 Apr;23(4):314-321. doi: 10.1017/S1355617717000145. Epub 2017 Mar 30.

PMID:
28357975
48.

Operationalizing compensation over time in neurodegenerative disease.

Gregory S, Long JD, Klöppel S, Razi A, Scheller E, Minkova L, Papoutsi M, Mills JA, Durr A, Leavitt BR, Roos RAC, Stout JC, Scahill RI, Langbehn DR, Tabrizi SJ, Rees G.

Brain. 2017 Apr 1;140(4):1158-1165. doi: 10.1093/brain/awx022. No abstract available.

49.

Optokinetic nystagmus reflects perceptual directions in the onset binocular rivalry in Parkinson's disease.

Fujiwara M, Ding C, Kaunitz L, Stout JC, Thyagarajan D, Tsuchiya N.

PLoS One. 2017 Mar 13;12(3):e0173707. doi: 10.1371/journal.pone.0173707. eCollection 2017.

50.

Stages of dysfunctional decision-making in addiction.

Verdejo-Garcia A, Chong TT, Stout JC, Yücel M, London ED.

Pharmacol Biochem Behav. 2018 Jan;164:99-105. doi: 10.1016/j.pbb.2017.02.003. Epub 2017 Feb 16. Review.

PMID:
28216068

Supplemental Content

Loading ...
Support Center